SPRY NASDAQ
ARS Pharmaceuticals, Inc.
1W: -10.8%
1M: -33.6%
3M: -28.7%
YTD: -50.6%
1Y: -68.3%
3Y: -21.6%
5Y: -82.6%
$5.67
-0.09 (-1.56%)
Weekly Expected Move ±8.3%
$5
$5
$6
$6
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$563.0M
52W Range5.62-18.5
Volume1,341,865
Avg Volume1,943,479
Beta0.88
Dividend—
Analyst Ratings
Company Info
CEODonn Casale
Employees163
SectorHealthcare
IndustryBiotechnology
IPO Date2020-12-04
Websitears-pharma.com
11682 El Camino Real
San Diego, CA 92130
US
San Diego, CA 92130
US
858 335 1300
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
Latest News
Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?
ARS Pharmaceuticals appoints new CEO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
Biggest stock movers Thursday: AI chip stocks, WEN, SPRY, and more
Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Casale Donn | A-Award | 898,456 | $7.96 | 2026-07-01 |
| Shah Pratik | A-Award | 30,000 | $10.54 | 2026-06-24 |
| Kelly Michael | A-Award | 30,000 | $10.54 | 2026-06-24 |
| Islam Saqib | A-Award | 30,000 | $10.54 | 2026-06-24 |
| Thompson Peter A. | A-Award | 30,000 | $10.54 | 2026-06-24 |